These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 25757067)

  • 41. Validating CFD Predictions of Pharmaceutical Aerosol Deposition with In Vivo Data.
    Tian G; Hindle M; Lee S; Longest PW
    Pharm Res; 2015 Oct; 32(10):3170-87. PubMed ID: 25944585
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhaled aerosol dose distribution between proximal bronchi and lung periphery.
    Verbanck S; Biddiscombe MF; Usmani OS
    Eur J Pharm Biopharm; 2020 Jul; 152():18-22. PubMed ID: 32361031
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characterization of respiratory drug delivery with enhanced condensational growth using an individual path model of the entire tracheobronchial airways.
    Tian G; Longest PW; Su G; Hindle M
    Ann Biomed Eng; 2011 Mar; 39(3):1136-53. PubMed ID: 21152983
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Controlled, Parametric, Individualized, 2-D and 3-D Imaging Measurements of Aerosol Deposition in the Respiratory Tract of Asthmatic Human Subjects for Model Validation.
    Fleming J; Conway J; Majoral C; Katz I; Caillibotte G; Pichelin M; Montesantos S; Bennett M
    J Aerosol Med Pulm Drug Deliv; 2015 Dec; 28(6):432-51. PubMed ID: 25859710
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Aerosol deposition in health and disease.
    Darquenne C
    J Aerosol Med Pulm Drug Deliv; 2012 Jun; 25(3):140-7. PubMed ID: 22686623
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of Posture on Regional Deposition of Coarse Particles in the Healthy Human Lung.
    Sá RC; Zeman KL; Bennett WD; Prisk GK; Darquenne C
    J Aerosol Med Pulm Drug Deliv; 2015 Dec; 28(6):423-31. PubMed ID: 25826480
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Surfactant-induced spreading of nanoparticles is inhibited on mucus mimetic surfaces that model native lung conditions.
    Schenck D; Goettler S; Fiegel J
    Phys Biol; 2019 Sep; 16(6):065001. PubMed ID: 31292288
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Deposition of coarse particles in cystic fibrosis: model predictions versus experimental results.
    Brown JS; Bennett WD
    J Aerosol Med; 2004; 17(3):239-48. PubMed ID: 15625816
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Assessing lung deposition of inhaled medications. Consensus statement from a workshop of the British Association for Lung Research, held at the Institute of Biology, London, U.K. on 17 April 1998.
    Snell NJ; Ganderton D
    Respir Med; 1999 Feb; 93(2):123-33. PubMed ID: 10464864
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Spreading of Oil Droplets Containing Surfactants and Pesticides on Water Surface Based on the Marangoni Effect.
    Liu J; Guo X; Xu Y; Wu X
    Molecules; 2021 Mar; 26(5):. PubMed ID: 33807893
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Surface rheological properties alter aerosol formation from mucus mimetic surfaces.
    Hamed R; Schenck DM; Fiegel J
    Soft Matter; 2020 Aug; 16(33):7823-7834. PubMed ID: 32756700
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Computational Models of Inhalation Therapy in Early Childhood: Therapeutic Aerosols in the Developing Acinus.
    Katan JT; Hofemeier P; Sznitman J
    J Aerosol Med Pulm Drug Deliv; 2016 Jun; 29(3):288-98. PubMed ID: 26907858
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Air and soul: the science and application of aerosol therapy.
    Rubin BK
    Respir Care; 2010 Jul; 55(7):911-21. PubMed ID: 20587104
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effect of biphasic inhalation profiles on the deposition and clearance of coarse (6.5 microm) bolus aerosols.
    Clark AR; Chambers CB; Muir D; Newhouse MT; Paboojian S; Schuler C
    J Aerosol Med; 2007; 20(1):75-82. PubMed ID: 17388755
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Wetting and Drying of Aqueous Droplets Containing Nonionic Surfactants C
    Shi J; Yang L; Bain CD
    Langmuir; 2021 Apr; 37(14):4091-4101. PubMed ID: 33797926
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Regional deposition of aerosolized interferon-gamma in pulmonary tuberculosis.
    Condos R; Hull FP; Schluger NW; Rom WN; Smaldone GC
    Chest; 2004 Jun; 125(6):2146-55. PubMed ID: 15189935
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In silico evaluation of particle transport and deposition in the airways of individual patients with chronic obstructive pulmonary disease.
    Kadota K; Matsumoto K; Uchiyama H; Tobita S; Maeda M; Maki D; Kinehara Y; Tachibana I; Sosnowski TR; Tozuka Y
    Eur J Pharm Biopharm; 2022 May; 174():10-19. PubMed ID: 35351571
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Aerosol deposition in the human lung in reduced gravity.
    Darquenne C
    J Aerosol Med Pulm Drug Deliv; 2014 Jun; 27(3):170-7. PubMed ID: 24870702
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Deposition of aerosol particles and flow resistance in mathematical and experimental airway models.
    Kim CS; Brown LK; Lewars GG; Sackner MA
    J Appl Physiol Respir Environ Exerc Physiol; 1983 Jul; 55(1 Pt 1):154-63. PubMed ID: 6885565
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Factors influencing polycation/siRNA colloidal stability toward aerosol lung delivery.
    Steele TW; Zhao X; Tarcha P; Kissel T
    Eur J Pharm Biopharm; 2012 Jan; 80(1):14-24. PubMed ID: 21924355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.